Montelukast Sodium Market Report 2026

Montelukast Sodium Market Overview

• Montelukast Sodium market size has reached to $4.2 billion in 2025 • Expected to grow to $6.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Rising Prevalence Of Asthma Fuels Growth In The Montelukast Sodium Market • Market Trend: Pharma Companies Focus On Innovative Combination Therapies For Enhanced Allergy And Asthma Relief • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Montelukast Sodium Market?

Montelukast sodium is a leukotriene receptor antagonist, meaning it works by blocking the action of leukotrienes that cause asthma symptoms and allergic reactions. It is used to manage and prevent symptoms of asthma and to relieve seasonal and perennial allergic rhinitis. Montelukast is typically administered orally in tablet form. The main product types of montelukast sodium are crystal-like, form-less, or amorphous. Crystal-like refers to a solid substance that exhibits a regular, repeating three-dimensional arrangement of its atoms or molecules. The various dosage forms include tablets and oral solutions. These are used in various applications such as bronchospasm, allergic coryza, asthma, urticaria, others

What Is The Montelukast Sodium Market Growth Forecast?

The montelukast sodium market size is expected to see strong growth in the next few years. It will grow to $6.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to rising global burden of asthma and allergic rhinitis, growing pediatric asthma diagnosis rates, increased awareness of non-steroidal asthma therapies, expanding access to respiratory medicines in emerging markets, continued demand for oral maintenance drugs. Major trends in the forecast period include rising demand for leukotriene receptor antagonists in asthma management, growing use of montelukast in allergic rhinitis treatment, expansion of generic montelukast sodium formulations, preference for oral solid dosage forms in chronic respiratory therapy, increased prescriptions for pediatric and adult asthma patients.

Global Montelukast Sodium Market Segmentation

1) By Product: Crystal-like, Form-less Or Amorphous 2) By Dosage Form: Tablets, Oral Solutions 3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications Subsegments: 1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium 2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

What Is The Driver Of The Montelukast Sodium Market?

The increasing prevalence of asthma is expected to propel the growth of montelukast sodium market going forward. Asthma is a chronic respiratory disorder marked by inflammation and constriction of the airways, resulting in repeated bouts of wheezing, breathlessness, chest tightness, and coughing. The prevalence of asthma is increasing due to environmental pollution, allergen exposure, genetic predisposition, urbanization, changes in lifestyle, and respiratory infections. Montelukast sodium is used in asthma as a leukotriene receptor antagonist, helping to prevent and manage asthma symptoms by blocking the action of leukotrienes, which contribute to airway inflammation and constriction. For instance, in October 2024, according to the National Asthma Council, an Australia-based non-profit organization, in 2023, Australia recorded a total of 474 asthma-related deaths, comprising 325 females and 149 males. This figure is almost identical to the 473 asthma-related deaths reported in 2022, highlighting a consistent trend in asthma mortality over the two years. Therefore, the increasing prevalence of asthma is driving the growth of montelukast sodium industry.

Key Players In The Global Montelukast Sodium Market

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Global Montelukast Sodium Market Trends and Insights

Major companies operating in the montelukast sodium market are focusing on developing innovative solutions, such as combination therapies, to provide broader allergy and asthma relief and improve patient adherence. Combination therapies are treatments that use two or more drugs together in a single regimen to target multiple pathways of a disease for better efficacy. For instance, in October 2025, Cadila Pharmaceuticals Ltd., an India-based pharmaceutical company, launched Dlorfast-M tablets, a fixed-dose combination therapy containing desloratadine (5 mg) and montelukast (10 mg) for the management of allergic rhinitis and urticaria. It provides broad symptom control by targeting both histamine and leukotriene pathways in a convenient once-daily oral dosage. This innovative formulation aims to improve patient compliance and deliver long-term relief with good tolerability.

What Are Latest Mergers And Acquisitions In The Montelukast Sodium Market?

In April 2024, Apotex Inc., a Canada-based pharmaceutical company,acquired Searchlight Pharma Inc. for an undisclosed amount. Through this acquisition, Apotex aims to accelerate its expansion into the branded and specialty pharmaceuticals market by integrating Searchlight’s portfolio of innovative and specialty-focused products. Searchlight Pharma Inc. is a Canada-based specialty-branded pharmaceutical company.

Regional Insights

North America was the largest region in the montelukast sodium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Montelukast Sodium Market?

The montelukast sodium market consists of sales of monteluksast oral granules, chewable tablets, pill organizers, dosing spoons and syringes, and tablet packaging material. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Montelukast Sodium Market Report 2026?

The montelukast sodium market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the montelukast sodium industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.